Attached files

file filename
10-Q - QUARTERLY REPORT - AYTU BIOPHARMA, INCf10q0318_aytubioscience.htm
EX-31.2 - CERTIFICATION - AYTU BIOPHARMA, INCf10q0318ex31-2_aytubio.htm
EX-31.1 - CERTIFICATION - AYTU BIOPHARMA, INCf10q0318ex31-1_aytubio.htm

Exhibit 32.1




Certification Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the filing of the quarterly report on Form 10-Q for the quarter ended March 31, 2018 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:


1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and


2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 14, 2018

/s/ Joshua R. Disbrow

  Joshua R. Disbrow
  Chief Executive Officer
Dated: May 14, 2018

/s/ David A. Green

  David A. Green
  Chief Financial Officer